Skip Navigation



American Journal of Epidemiology Advance Access published online on October 31, 2007
American Journal of Epidemiology, doi:10.1093/aje/kwm303
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
166/12/1479    most recent
kwm303v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dören, M.
Right arrow Articles by Greiser, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dören, M.
Right arrow Articles by Greiser, E. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology © The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Letter to the Editor

RE: "INVITED COMMENTARY: HORMONE THERAPY AND RISK OF CORONARY HEART DISEASE—WHY RENEW THE FOCUS ON THE EARLY YEARS OF MENOPAUSE?"

Martina Dören1 and Eberhard M. Greiser2

1 Clinical Research Center of Women's Health, Charité-Universitätsmedizin Berlin, D-12200 Berlin, Germany
2 Institute for Public Health and Nursing Research, Faculty of Health Sciences, Bremen University, D-28259 Bremen, Germany

(e-mail: martina.doeren@charite.de)

The first 10% of the full text of this article appears below.

The meta-analysis by Salpeter et al. (1) is ineligible to support the validity of the "timing hypothesis" discussed by Manson and Bassuk in a recent Journal article (2), because this work suffers from methodological shortcomings. The objective to disentangle associations between coronary heart disease and use of menopausal hormone therapies was obscured by including not only trials with defined coronary heart disease events, monitored . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?